Accendra Health Inc/Va/ (New York Stock Exchange:ACH)
| Market Cap | 33.97M-90.6% |
| Revenue (ttm) | 2.65B-60.5% |
| Net Income | -302.14M+74.9% |
| EPS | -3.91+75.0% |
| Shares Out | 76.58M |
| PE Ratio | n/a |
| Forward PE | 3.77 |
| Dividend | n/a |
| Ex-Dividend Date | Dec 14, 2021 |
| Volume | 310,689 |
| Open | 0.48 |
| Previous Close | 0.47 |
| Day's Range | 0.44 - 0.49 |
| 52-Week Range | 0.44 - 5.60 |
| Beta | 1.57 |
| Analysts | Hold |
| Price Target | 1.50(+238.14%) |
| Earnings Date | Oct 29, 2026 |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ACH
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
$ACH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ACH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ACH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ACH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ACH Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Cost of net revenue | $349.83M | 52.47% |
| Cost of product sold | $311.51M | 46.73% |
| Other costs | $5.32M | 0.80% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ACH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ACH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ACH
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $2.65M |
| VFVAVanguard U.S. Value Factor ETF | $1.46M |
| VXFVanguard Extended Market ETF | $1.01M |
| IWMiShares Russell 2000 ETF | $933.85K |
| FNDASchwab Fundamental U.S. Small Company Index ETF | $586.21K |
| VTWOVanguard Russell 2000 ETF | $499.80K |
Estimated from each fund’s disclosed top holdings × AUM
ACH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ACH’s recent data — informational, not investment advice